As of 2025-09-18, the Relative Valuation of Cardiff Oncology Inc (CRDF) is (10.62) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.01 USD, the upside of Cardiff Oncology Inc based on Relative Valuation is -628.4%.
The range of the Relative Valuation is (8.53) - (11.95) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.1x - 15.6x | 13.9x |
| Forward P/E multiples | 11.0x - 17.0x | 13.8x |
| Fair Price | (8.53) - (11.95) | (10.62) |
| Upside | -524.3% - -694.4% | -628.4% |
| Date | P/E |
| 2025-09-16 | -2.61 |
| 2025-09-15 | -2.66 |
| 2025-09-12 | -2.67 |
| 2025-09-11 | -2.71 |
| 2025-09-10 | -2.66 |
| 2025-09-09 | -2.78 |
| 2025-09-08 | -2.91 |
| 2025-09-05 | -2.83 |
| 2025-09-04 | -2.78 |
| 2025-09-03 | -2.56 |
| 2025-09-02 | -2.54 |
| 2025-08-29 | -2.74 |
| 2025-08-28 | -2.71 |
| 2025-08-27 | -2.83 |
| 2025-08-26 | -2.88 |
| 2025-08-25 | -2.88 |
| 2025-08-22 | -3.03 |
| 2025-08-21 | -2.95 |
| 2025-08-20 | -2.97 |
| 2025-08-19 | -3.00 |
| 2025-08-18 | -3.17 |
| 2025-08-15 | -3.18 |
| 2025-08-14 | -3.18 |
| 2025-08-13 | -3.19 |
| 2025-08-12 | -3.17 |
| 2025-08-11 | -3.04 |
| 2025-08-08 | -3.12 |
| 2025-08-07 | -3.14 |
| 2025-08-06 | -3.18 |
| 2025-08-05 | -3.35 |
| 2025-08-04 | -3.27 |
| 2025-08-01 | -3.44 |
| 2025-07-31 | -3.09 |
| 2025-07-30 | -3.25 |
| 2025-07-29 | -4.32 |
| 2025-07-28 | -4.86 |
| 2025-07-25 | -5.18 |
| 2025-07-24 | -5.40 |
| 2025-07-23 | -5.59 |
| 2025-07-22 | -4.93 |
| 2025-07-21 | -5.10 |
| 2025-07-18 | -5.58 |
| 2025-07-17 | -5.80 |
| 2025-07-16 | -5.76 |
| 2025-07-15 | -5.37 |
| 2025-07-14 | -5.39 |
| 2025-07-11 | -5.31 |
| 2025-07-10 | -5.42 |
| 2025-07-09 | -5.32 |
| 2025-07-08 | -5.14 |